___

• Bakterial vaginosis: review of treatment options and potential clinical indications for therapy. Clinical Infectious Diseases. 20 Suppl l:S72-9, 1995 Apr.
• Value of the score for Gram stains in the diagnosis of bacterial vaginosis. Pathologie Biologie. 42(5):539-43, 1994 May.
• Diagnosis and prevalence of bacterial vaginosis. Journal of Postgraduate Medicine. 39(2):3, 1993 Apr-Jun.
• Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstetrica et Gynecologica Scandinavica. 72(1):17-9, 1993 Jan.
• Economical treatment of bacterial vaginosis. Japanese Journal of Antibiotics. 48(3):432-6, 1995 Mar.
• Diagnosis of bacterial vaginosis in a routine diagnostic laboratory. Medical Laboratory Sciences. 49(1):8-11, 1992 Mar.
• Risk factors for gonorrhea, syphilis and trichomonas infections among women attending family planning clinics in Nairobi, Kenya. Genitourinary Medicine 70 (3):155-61, 1994 Jun.
• A double-blind placebo-controlled trial of single-dose intravaginal versus single-dose oral metronidazole in the treatment of trichomonal vaginitis. Journal of Infectious Diseases. 170(1):242-6, 1994 Jul.
• Jinekoloji polikliniğine başvuran kadınlarda Trichomonas vaginalis araştırılması. Mikrobiyoloji Bülteni. 27(4):357-63, 1993 Oct.
• Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Dug Administration. Clinical Infectious Diseases. 15 Suppl 1:S115-22, 1992 Nov.
• Treatment options for vulvovaginal candidiasis, 1993 Review. Clinical Infectious Diseases. 20 Suppl 1:S80-90, 1995 Apr.
• Neotran - a new double - active pessary for the treatment of vaginitis. Journal of International Medical Research. 21(1): 36 -46, 1993 Jan - Feb
• Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis Obstetrics and Gynecology. 81(5(Pt l)): 721 - 7, 1993 May
• The epidemiology of vulvovaginal candidiasis among university students. American Journal ofPublic Health. 85(8 Ptl):1146-8,1995 Aug.
• Topical antifungal agents. Review Obstetrics and Gynecology Clinics of North America. 19(3):587- 607, 1992 Sep.
• Blackwell AL, Fox AR, Phillips I, et al: Anaerobic vaginosis (nonspecific vaginosis): Clinical, microbiological and therapeutic findings. Lancet 2:1379-1382, 1982.
• Spiegel CA, Amsel R, Eschenbach DA, et al: Anaerobic bacteria in nonspecific vaginitis. N England J Med 303:601 - 607, 1980.
• Spiegel CA, Amsel R, Eschenbach DA, et al: Anaerobic bacteria in nonspecific vaginitis. N England J Med 303:601 - 607, 1980.
• Holmes K.K, Chen KCS, Lipinski CM et al : Vaginal redox potential in bacterial vaginosis (nonspecific vaginitis). J Infect Dis 152:79-82, 1985
• Holst E, Wathne B, Hovelius B, et al : Bacterial vaginosis: Microbiologic and clinical findings. Eur J Clin Microbiol 6: 536-541, 1987.
• Paavonen J, Miettinen A, Stevens CE, et al: Mycoplasma Hominis in nonspecific vaginitis. Sex Transm Dis 10 (suppl): 271-275, 1983
• Eschenbach DA, Hillier S, Critchlow C, et al: Diagnosis and clinical manifestation of bacterial vaginosis. Am J Obstet Gynecol 158:819-828, 1988
• Pheifer TA, Forsyth PA, Durfee MA, et al: Nonspecific vaginitis: Role of Haemophilus vaginalis and treatment of metronidazole. N Engl J Med 298:14291434, 1978
• Brand TM, Galask RP: Trimethylamine: The substance mainly responsible for the fishy odor often associated with bacterial vaginosis. Obstet Gynecol 68:682685, 1986
• Chen KCS, Forsyth PS, Buchanan TM, et al: Amine content of vaginal fluid from untreated patients with nonspecific vaginitis. J Clin Invest 63:828-835, 1979
• Spiegel CA, Amsel R, Holmes KK: Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol 18:170-177, 1983
• Guys E: Sites of colonization of T. Vaginalis. Parazit 10:22, 1984
• Fouts A, Kraus S: Trichomonas Vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 141: 137, 1980
• Spence M: The clinical and laboratory diagnosis of T. vaginalis infection. Sex Transm Dis 7: 188, 1980
• Senanayake P. Kramer DG: Contraception and the etiology of pelvic inflammatory disease: New perspectives. Am J Obstet Gynecol 138:852-860, 1980
• Cramer DW, Schiff I, Schoenbaum SC, et al: Tubal infertility and the intrauterine device. N Engl J Med 312:941-949, 1985
• Daling JR, Weiss NS, Metch BJ, et al : Primary tuba! infertility in relation to the use of an intrauterine device. N Engl J Med 312:937-945, 1985
• Lee NC, Robin GL, Borucki R: The intrauterine device and pelvic inflamatory disease revisited: New results from the Women's Health Study. Obstet Gynecol 72:1,1988
• Johns DR, i Tierney M, Felsenstein D: Alteration in the natural history of neurosyphillis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316: 1569, 1987
• Lukehart SA, Hook EW, Baker- Zander SA, et al : In vasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med 109: 855, 1988
• Radolf JD, Kaplan RP: Unusual manifestation of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 18:432, 1988
• Larsen SA, Hunter EF, Mc Grew BE: Syphilis. In Wentworth BB, Judson FN (eds):Laboratory Methods for the Diagnosis of Sexually Transmitted Diseases. Washington DC, American Public Health Association, 1984 p 1
• Mascola L, Pelosi R, Alexander CE : Inadequate treatment of syphilis in pregnancy. Am J Obstet Gynecol 150:945, 1984
• Philipson A, Sabath LD, Charles D: Transplacental passage of Erytromycin and Clindamycin. N Engl J Med 288: 1219, 1973